Co-Authors
This is a "connection" page, showing publications co-authored by Vincent Cheng and Ivan Hung.
Connection Strength
0.896
-
Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong. Am J Infect Control. 2020 08; 48(8):890-896.
Score: 0.221
-
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev. 2012 Apr; 25(2):223-63.
Score: 0.126
-
Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004 Sep; 10(9):1550-7.
Score: 0.074
-
Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004 Feb 15; 38(4):467-75.
Score: 0.071
-
Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples. Expert Rev Mol Diagn. 2021 07; 21(7):741-747.
Score: 0.059
-
Factors affecting stability and infectivity of SARS-CoV-2. J Hosp Infect. 2020 Oct; 106(2):226-231.
Score: 0.056
-
Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. Clin Microbiol Infect. 2019 Dec; 25(12):1539-1545.
Score: 0.051
-
Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect. 2019 Mar; 25(3):372-378.
Score: 0.048
-
Middle East Respiratory Syndrome Interpreted: Human Herpesvirus 6B Pneumonia. Am J Med. 2016 09; 129(9):945-7.
Score: 0.042
-
SARS coronavirus detection methods. Emerg Infect Dis. 2005 Jul; 11(7):1108-11.
Score: 0.020
-
Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol. 2005 May; 79(10):6180-93.
Score: 0.019
-
Initial viral load and the outcomes of SARS. CMAJ. 2004 Nov 23; 171(11):1349-52.
Score: 0.019
-
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004 Sep; 31(1):69-75.
Score: 0.019
-
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet. 2004 Mar 13; 363(9412):841-5.
Score: 0.018
-
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar; 59(3):252-6.
Score: 0.018
-
Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004 Feb; 10(2):294-9.
Score: 0.018
-
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24; 361(9371):1767-72.
Score: 0.017